In this article we will provide 10 medical revision notes about atrial fibrillation (AF).
Key Points
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, characterised by an irregularly irregular heart rate
It increases the risk of stroke, heart failure, and other cardiovascular complications
Treatment includes rate control, rhythm control, and anticoagulation
Management should be tailored to the individual, considering the patient’s symptoms, comorbidities, and risk factors
Think about the cause(s) and effect(s) of AF in each patient.
Typical AF on ECG
1. Definition
Atrial fibrillation (AF) is a supraventricular tachyarrhythmia caused by disorganised electrical activity in the atria, leading to ineffective atrial contraction. It is characterised by an irregularly irregular pulse and the absence of distinct P waves on an ECG. AF can be classified as:
Paroxysmal: Intermittent episodes that terminate spontaneously within 7 days
Persistent: Sustained beyond 7 days, or requiring intervention for termination
Permanent: Long-standing AF where attempts to restore sinus rhythm have been unsuccessful or not pursued.
2. Epidemiology
AF affects approximately 1–2% of the UK population, and its prevalence increases with age
It is more common in men than women
The incidence rises sharply in those over the age of 65, affecting about 10% of individuals over 80 years old
AF is a significant cause of morbidity and mortality due to its association with stroke and heart failure.
3. Risk factors
Age: Risk increases significantly with advancing age
Hypertension: One of the most common predisposing factors
Heart disease: Including heart failure, ischaemic heart disease (IHD) and valvular heart disease
Note 1. The ‘big three’ are mitral valve disease, ischaemic heart disease and hyperthyroidism. These need to be actively excluded Note 2. ‘Lone AF‘ – also occurs. This is a phrase for AF when there is no obvious cause (especially cardiac).
5. Symptoms
Palpitations: A common presenting symptom, often described as a rapid, irregular heart rate (in fast AF; slow AF also occurs)
Fatigue and reduced exercise tolerance: Due to inefficient cardiac output
Dyspnoea: Shortness of breath, particularly during exertion
Dizziness or lightheadedness: Related to reduced cerebral perfusion
Chest discomfort: May present as mild discomfort or more significant pain
Asymptomatic: Some patients may be diagnosed incidentally during routine examination or screening.
6. Diagnosis
History and examination: Look for an irregularly irregular pulse and symptoms such as palpitations or dyspnoea. Consider possible triggers, associated conditions, and family history.
Investigation
ECG: The gold standard for diagnosis. Classic findings include the absence of P waves, irregular R-R intervals, and fibrillatory (f) waves
Holter monitoring: Useful if paroxysmal AF is suspected, especially when symptoms are intermittent
Echocardiogram: To assess underlying valvular and structural heart disease, left ventricular function, and left atrial size
Blood tests: Full blood count, renal and liver function tests, thyroid function tests, and coagulation screen
Chest x-ray: To rule out pulmonary causes of symptoms and assess heart size.
Differential diagnosis
Atrial flutter: Often presents with a regular rhythm but can be irregular if there is variable conduction.
Supraventricular tachycardia (SVT)
Ventricular ectopics or bigeminy
Multifocal atrial tachycardia (MAT)
Sinus tachycardia with frequent ectopic beats
7. Treatment
Rate control: Manage symptoms by controlling the ventricular rate. First-line agents include beta-blockers (e.g. bisoprolol), calcium channel blockers (e.g. diltiazem), or digoxin (especially in patients with heart failure)
Rhythm control: For patients with symptomatic AF where rate control is insufficient. Strategies include:
Pharmacological cardioversion: E.g. amiodarone, flecainide (in those without structural heart disease)
Electrical cardioversion
Catheter ablation: Considered for those with symptomatic, recurrent AF despite medical therapy.
Anticoagulation: Essential to reduce the risk of stroke. Use the CHA₂DS₂-VASc score to assess stroke risk and guide anticoagulation decisions. Options include:
Direct oral anticoagulants (DOACs): Apixaban, rivaroxaban, dabigatran, or edoxaban
Warfarin: If DOACs are unsuitable (e.g. severe renal impairment)
Lifestyle modifications: Addressing risk factors like hypertension, obesity, and alcohol intake.
8. Complications
Stroke: Due to embolisation of thrombus from the left atrium. Stroke risk is increased fivefold in AF patients
Heart failure: Can be precipitated or worsened by the arrhythmia
Tachycardia-induced cardiomyopathy
Increased mortality: Due to associated cardiovascular events.
9. Prognosis
Prognosis depends on underlying causes, associated comorbidities, and adherence to treatment
Effective rate and rhythm control, combined with appropriate anticoagulation, can significantly reduce the risk of complications and improve quality of life
The risk of recurrence is high, particularly in persistent and permanent AF, and lifelong follow-up is often required.
10. Prevention
Control of risk factors: Effective management of hypertension, diabetes, and other cardiovascular risk factors
Lifestyle changes: Reducing alcohol consumption, smoking cessation, weight loss, and treating sleep apnoea can help reduce the risk of developing AF
Early treatment: Identifying and treating reversible causes promptly (e.g. hyperthyroidism) may prevent the progression to sustained AF.
Summary
We have provided 10 medical revision notes about atrial fibrillation (AF). We hope it has been helpful.
Top Tip
In a patient without cardiovascular compromise (controlled heart rate, no heart failure), treatment does not need to start immediately. It may be paroxysmal AF. Arrange to see them again soon in clinic and make a decision then, after a repeat examination.